QQ客服 官方微博 反馈留言

	Enzymatic rhamnosylation of anticancer drugs by an alpha-l-rhamnosidase from Alternaria sp. L1 for cancer-targeting and enzyme-activated prodrug therapy
	Xu, Li; Liu, Xiaohong; Li, Yinping; Yin, Zhenhao; Jin, Lan; Lu, Lili; Qu, Jingyao; Xiao, Min
刊名	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
	2019
卷号	103期号:19页码:7997-8008
关键词	Rhamnosylation alpha-l-Rhamnosidase Alternaria sp L1 Cancer-targeting Prodrug
DOI	10.1007/s00253-019-10011-0
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4560178
专题	山东大学
作者单位	Shandong Univ, Shandong Prov Key Lab Carbohydrate Chem & Glycobi, Natl Glycoengn Res Ctr, Qingdao
推荐引用方式 GB/T 7714	Xu, Li,Liu, Xiaohong,Li, Yinping,et al. Enzymatic rhamnosylation of anticancer drugs by an alpha-l-rhamnosidase from Alternaria sp. L1 for cancer-targeting and enzyme-activated prodrug therapy[J]. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY,2019,103(19):7997-8008.
APA	Xu, Li.,Liu, Xiaohong.,Li, Yinping.,Yin, Zhenhao.,Jin, Lan.,...&Xiao, Min.(2019).Enzymatic rhamnosylation of anticancer drugs by an alpha-l-rhamnosidase from Alternaria sp. L1 for cancer-targeting and enzyme-activated prodrug therapy.APPLIED MICROBIOLOGY AND BIOTECHNOLOGY,103(19),7997-8008.
MLA	Xu, Li,et al."Enzymatic rhamnosylation of anticancer drugs by an alpha-l-rhamnosidase from Alternaria sp. L1 for cancer-targeting and enzyme-activated prodrug therapy".APPLIED MICROBIOLOGY AND BIOTECHNOLOGY 103.19(2019):7997-8008.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。